| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/07/1993 | CA1321994C Acylated uridine and cytidine and uses thereof |
| 09/05/1993 | CA2090170A1 Tetrahydropyrimidine derivatives |
| 09/04/1993 | CA2090785A1 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/02/1993 | WO1993017025A1 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity |
| 09/02/1993 | WO1993017019A1 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist |
| 09/02/1993 | WO1993017018A1 Nitrosation process |
| 09/02/1993 | WO1993017017A1 [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
| 09/02/1993 | WO1993017012A1 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
| 09/02/1993 | WO1993017004A1 Benzisoxazole derivatives and pharmaceutical compositions containing them |
| 09/02/1993 | WO1993016999A1 Benzodiazepin derivatives useful as cck-receptor antagonists |
| 09/02/1993 | WO1993016997A1 2,3,4,5-TETRAHYDRO-1H^_-3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF α-SUBSTITUTED-ARYLACETAMIDES |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | WO1993016706A1 Use of substituted adenine derivatives for treating multiple sclerosis |
| 09/02/1993 | WO1993016701A2 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 09/02/1993 | WO1993016700A1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and ×dema |
| 09/02/1993 | WO1993016689A1 Pharmaceutical composition for use as a pain killer and containing (benzoyl-3 phenyl)-2 propionic-(r) acid |
| 09/02/1993 | WO1993016686A1 Pharmaceutical preparation for sustained release of a drug and process for producing the same |
| 09/02/1993 | WO1993015112A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |
| 09/01/1993 | EP0558416A1 New 17-(methylene)-lactone spiro condensed steroids, method and intermediates for their production, their use as medicines and pharmaceutical compositions containing them |
| 09/01/1993 | EP0558156A2 Intermediates for 3-aminopiperidine derivates |
| 09/01/1993 | EP0557497A1 NEW $g(b)-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS |
| 09/01/1993 | EP0557385A1 Topical compositions for transdermal delivery of produg derivatives of morphine |
| 09/01/1993 | EP0557375A1 New heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use |
| 09/01/1993 | EP0557290A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
| 09/01/1993 | CN1075717A Benzodiazepine derivatives |
| 09/01/1993 | CN1075631A Drug with the effect of resisting and preventing tension and intelligence-promoting |
| 08/31/1993 | US5241065 Selectively antagonize dopamine D-1 receptors |
| 08/31/1993 | US5240946 ((2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino)alkyl)-acid derivatives |
| 08/31/1993 | US5240933 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphine and -norisomorphine, processes for the preparation thereof and the use thereof as pharmaceutical compositions |
| 08/31/1993 | US5240927 Benzo[β]thiophen-3-yl piperazines as antipsychotic agents |
| 08/31/1993 | US5240919 Benzthiazolinonyl-substituted alkylamides |
| 08/31/1993 | US5240662 Process for the preparation of solid pharmaceutical compositions |
| 08/31/1993 | CA1321849C Adhesive compositions, controlled release compositions and transdermal drug delivery device |
| 08/31/1993 | CA1321792C Piperidine opioid antagonists |
| 08/31/1993 | CA1321753C Method for inhibiting loss of cognitive functions employing an ace inhibitor |
| 08/25/1993 | EP0557065A1 Spheroid formulation |
| 08/25/1993 | EP0557064A1 Modified release formulation |
| 08/25/1993 | EP0556778A2 Xanthine derivatives |
| 08/25/1993 | EP0556482A2 Propyl endopeptidase inhibitor |
| 08/25/1993 | EP0556218A1 Local anaesthetic. |
| 08/24/1993 | US5238953 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept (b) indole |
| 08/24/1993 | US5238932 Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 08/24/1993 | US5238688 Method for preparing a powdered particulate composition |
| 08/24/1993 | CA1321587C Quinoxaline compounds and their preparation and use |
| 08/19/1993 | WO1993016103A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 08/19/1993 | WO1993016082A1 4-oxo- and 4h-imidazo(5,1-c)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents |
| 08/19/1993 | WO1993016074A1 Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same |
| 08/19/1993 | WO1993016073A1 Piperazine and piperidine derivatives, and their use as antipsychotics |
| 08/19/1993 | WO1993016072A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists |
| 08/19/1993 | WO1993016051A1 Arylalkoxyphenoxy-imidazoline compounds |
| 08/19/1993 | WO1993016050A1 Antipsychotic nitrogen-containing bicyclic compounds |
| 08/19/1993 | WO1993016049A1 Novel pyridone derivatives, preparation method therefor, novel intermediates thereby obtained, their use as drugs, and pharmaceutical compositions containing same |
| 08/19/1993 | WO1993016047A1 Hydroisoindolines and hydroisoquinolines as psychotropic drugs |
| 08/19/1993 | WO1993015608A1 Prevention of retinal injury and degeneration by specific factors |
| 08/19/1993 | WO1993014070A3 Novel imidazole derivatives, their preparation and therapeutic applications |
| 08/19/1993 | CA2130123A1 Hydroisoindolines and hydroisoquinolines as psychotropic |
| 08/19/1993 | CA2130110A1 Antipsychotic-nitrogen-containing bicyclic compounds |
| 08/19/1993 | CA2129142A1 Arylalkoxyphenoxy-imidazoline compounds |
| 08/19/1993 | CA2129112A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists |
| 08/19/1993 | CA2117434A1 Piperazine and piperidine derivatives, and their use as antipsychotics |
| 08/19/1993 | CA2106758A1 Novel pyridone derivatives, a process for their preparation, novel intermediates thereof, their application as drugs and pharmaceutical compositions holding same |
| 08/18/1993 | EP0556080A1 Bicyclic pyridine derivatives, process for their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them |
| 08/18/1993 | EP0556008A1 Condensed imidazopyridine derivatives with psychotropic activity |
| 08/18/1993 | EP0555898A2 Medicaments for non-topical use |
| 08/18/1993 | EP0555446A1 USE OF ANTAGONISTS OR PARTIAL AGONISTS ON THE 5-HT 1a? RECEPTOR FOR THE TREATMENT AND PREVENTION OF COGNITIVE DISORDERS |
| 08/18/1993 | EP0555391A1 Certain imidazoquinoxalines; a new class of gaba brain receptor ligands |
| 08/18/1993 | EP0555327A1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 08/18/1993 | EP0555302A1 Method of treating demyelinating disease |
| 08/18/1993 | EP0339075B1 Acylated uridine and cytidine and uses thereof |
| 08/18/1993 | CN1021825C Prepn. for aromatic w-alkylimide-tetrahydro-6h-1,3-thiazine-6-one derivatives |
| 08/17/1993 | US5236957 Antiepileptic agents |
| 08/17/1993 | US5236908 Using adenosine antagonist |
| 08/17/1993 | US5236714 Administering abuse substance in permeable form in conjunction with an antagonist in impermeable form; eliminates immediate "high" without diminishing therapeutic value |
| 08/17/1993 | CA1321349C Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
| 08/11/1993 | EP0554887A1 The use of mammalian liver extract for the manufacture of a medicament to treat presenile or senile dementia |
| 08/11/1993 | EP0554861A1 The use of inositoltriphosphate for the treatment of renal diseases |
| 08/11/1993 | EP0554829A2 Pyrazole derivatives with antiinflammatory, analgesic and antithrombolic activity |
| 08/11/1993 | EP0554794A1 Aminobenzoic acid derivatives |
| 08/11/1993 | EP0554543A2 1,2,4-Triaminobenzene derivatives and process for their preparation |
| 08/11/1993 | EP0554436A1 Gaba receptor modulators |
| 08/11/1993 | EP0554352A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 08/11/1993 | EP0554247A1 Neuroprotective indolone and related derivatives |
| 08/11/1993 | EP0396620B1 Aminomethyl-chroman and -thiochroman compounds |
| 08/11/1993 | CN1075145A Aminobenzoic acid derivatives |
| 08/10/1993 | US5235055 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 08/10/1993 | US5235043 Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| 08/10/1993 | US5234956 Reducing increase in calcium ion concenration; administering nitroglycerin, nitroprusside or derivatives thereof; treating AIDS, Alzheimer's, CNS disorders, cardiovascular disorders |
| 08/10/1993 | US5234947 Potassium channel activating compounds and methods of use thereof |
| 08/10/1993 | US5234930 Pyrazolopyridine compounds which have useful pharmaceutical utility |
| 08/10/1993 | US5234927 Magnesium oxide as a biodegradation retarding agent |
| 08/10/1993 | US5234405 Brain resuscitation device and method for performing the same |
| 08/10/1993 | CA1321199C Chloroaniline derivatives |
| 08/10/1993 | CA1321195C Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
| 08/06/1993 | CA2088835A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| 08/06/1993 | CA2087781A1 Method of treating presenile or senile dementia |
| 08/05/1993 | WO1993015112A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 08/05/1993 | WO1993015080A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | WO1993015073A1 Azabricyclic compounds as calcium channel antagonists |